학술논문

Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.
Document Type
Article
Source
Biomedicines; Sep2022, Vol. 10 Issue 9, p2216-2216, 16p
Subject
CHIMERIC antigen receptors
OVARIAN epithelial cancer
T cells
DISEASE remission
HEMATOLOGIC malignancies
HISTOCOMPATIBILITY antigens
OVARIAN cancer
Language
ISSN
22279059
Abstract
Copyright of Biomedicines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)